PRM112 - INCORPORATION OF ANTI-CANCER DRUGS ADVERSE EVENTS IN HEALTH ECONOMIC OPINIONS OF THE FRENCH NATIONAL AUTHORITY FOR HEALTH (HAS)
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2232
https://www.valueinhealthjournal.com/article/S1098-3015(18)35534-7/fulltext
Title :
PRM112 - INCORPORATION OF ANTI-CANCER DRUGS ADVERSE EVENTS IN HEALTH ECONOMIC OPINIONS OF THE FRENCH NATIONAL AUTHORITY FOR HEALTH (HAS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35534-7&doi=10.1016/j.jval.2018.09.2232
First page :
Section Title :
Open access? :
No
Section Order :
1588